Acurx Pharmaceuticals, Inc.

As of June 18, 2025, the market trend is neutral with mixed indicators, showing a shift from mildly bearish to sideways, as weekly signals are mildly bullish while monthly signals remain bearish.

Acurx Pharmaceuticals, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $2 million and a market cap of $19.27 million. The company has no dividend yield and significant negative financial metrics.

As of Jun 18, Acurx Pharmaceuticals, Inc. has a market capitalization of 19.27 million, with net sales of 0.00 million and a net profit of -11.87 million over the last four quarters. The company reported shareholder's funds of 0.62 million and total assets of 3.86 million as of Dec 24.